» Articles » PMID: 12771946

A Major Role for Mcl-1 Antiapoptotic Protein in the IL-6-induced Survival of Human Myeloma Cells

Overview
Journal Oncogene
Date 2003 May 29
PMID 12771946
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

Interleukin-6 (IL-6) is a major survival factor for malignant plasma cells involved in multiple myeloma. Using an RNase protection assay, we looked for gene expression of 10 anti- and proapoptotic Bcl-2-family proteins in 12 IL-6-dependent human myeloma cell lines (HMCL). A high Mcl-1 gene expression was found in all HMCLs and the other genes were variably expressed. Out of the 10 Bcl-2-family members, only the Mcl-1 gene was regulated by IL-6. Upon starvation of IL-6, Mcl-1 gene expression decreased in association with myeloma cell apoptosis and was upregulated after adding IL-6 again in association with myeloma cell survival. A constitutive Mcl-1 expression was induced with an Mcl-1-GFP retrovirus in two IL-6-dependent HMCLs. The Mcl-1 HMCLs have a marked reduced apoptosis upon IL-6 starvation compared to HMCLs transduced with control GFP retrovirus and may grow without adding IL-6. These data emphasize the major role of Mcl-1 antiapoptotic protein in the IL-6-induced survival of human myeloma cells.

Citing Articles

Interleukin-6 Modulation in Ovarian Cancer Necessitates a Targeted Strategy: From the Approved to Emerging Therapies.

Amer H, Kampan N, Itsiopoulos C, Flanagan K, Scott C, Kartikasari A Cancers (Basel). 2025; 16(24.

PMID: 39766086 PMC: 11674514. DOI: 10.3390/cancers16244187.


Gammaherpesvirus Infection Stimulates Lung Tumor-Promoting Inflammation.

Mukhopadhyay S, Swan K, Pridjian G, Kolls J, Zhuang Y, Yin Q Pathogens. 2024; 13(9).

PMID: 39338937 PMC: 11434807. DOI: 10.3390/pathogens13090747.


CX3CR1-Expressing Immune Cells Infiltrate the Tumor Microenvironment and Promote Radiation Resistance in a Mouse Model of Lung Cancer.

Ben-Mordechai T, Lawrence Y, Symon Z, Shimoni-Sebag A, Amit U Cancers (Basel). 2023; 15(22).

PMID: 38001732 PMC: 10669975. DOI: 10.3390/cancers15225472.


Critical role of TLR activation in viral replication, persistence, and pathogenicity of Theiler's virus.

Kim B Front Immunol. 2023; 14:1167972.

PMID: 37153539 PMC: 10157096. DOI: 10.3389/fimmu.2023.1167972.


Autophagy: A Potential Therapeutic Target to Tackle Drug Resistance in Multiple Myeloma.

Bashiri H, Tabatabaeian H Int J Mol Sci. 2023; 24(7).

PMID: 37046991 PMC: 10094562. DOI: 10.3390/ijms24076019.


References
1.
Zhang B, Gojo I, Fenton R . Myeloid cell factor-1 is a critical survival factor for multiple myeloma. Blood. 2002; 99(6):1885-93. DOI: 10.1182/blood.v99.6.1885. View

2.
Le Baccon P, Leroux D, Dascalescu C, Duley S, Marais D, Esmenjaud E . Novel evidence of a role for chromosome 1 pericentric heterochromatin in the pathogenesis of B-cell lymphoma and multiple myeloma. Genes Chromosomes Cancer. 2001; 32(3):250-64. DOI: 10.1002/gcc.1189. View

3.
Shigemasa K, Katoh O, Shiroyama Y, Mihara S, Mukai K, Nagai N . Increased MCL-1 expression is associated with poor prognosis in ovarian carcinomas. Jpn J Cancer Res. 2002; 93(5):542-50. PMC: 5927039. DOI: 10.1111/j.1349-7006.2002.tb01289.x. View

4.
Rassidakis G, Lai R, McDonnell T, Cabanillas F, Sarris A, Medeiros L . Overexpression of Mcl-1 in anaplastic large cell lymphoma cell lines and tumors. Am J Pathol. 2002; 160(6):2309-10. PMC: 1850807. DOI: 10.1016/S0002-9440(10)61178-9. View

5.
Derenne S, Monia B, Dean N, Taylor J, Rapp M, Harousseau J . Antisense strategy shows that Mcl-1 rather than Bcl-2 or Bcl-x(L) is an essential survival protein of human myeloma cells. Blood. 2002; 100(1):194-9. DOI: 10.1182/blood.v100.1.194. View